For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, open, single-arm, the real world of clinical trials. The researchers
plan to recruit 300 eligible patients. The main purpose of this study is to evaluate the
effectiveness and safety of butylphthalide in the treatment of ischemic stroke, and to
establish a population pharmacokinetic model of butylphthalide in elderly patients to explore
its blood drug concentration. Correlation with its efficacy and adverse reactions.